title: Key Controversies in Colloid and Crystalloid Fluid Utilization.
abstract: Nearly 2 centuries have passed since the use of intravenous fluid became a foundational component of clinical practice. Despite a steady stream of published investigations on the topic, questions surrounding the choice, dose, timing, targets, and cost-effectiveness of various fluid options remain insufficiently answered. In recent years, 2 of the most debated topics reference the role of albumin in acute care and the safety of normal saline. Although albumin has a place in therapy for specific patient populations, its high cost relative to other fluids makes it a less desirable option for hospitals and health systems with escalating formulary scrutiny. Pharmacists bear responsibility for reconciling this disparity and supporting the rational use of albumin in acute care through a careful evaluation of recently published literature. In parallel, it has become clear that crystalloids should no longer be considered a homogenous class of fluids. The past reliance on normal saline has been questioned due to recent findings of renal dysfunction attributable to the solution's supraphysiologic chloride concentration. These safety concerns with 0.9% sodium chloride may result in a practice shift toward more routine use of "balanced crystalloids," such as lactated Ringer's or Plasma-Lyte, that mimic the composition of extracellular fluid. The purpose of this review is to summarize the evidence regarding these 2 important fluid controversies that are likely to affect hospital pharmacists in the coming decades - the evidence-based use of human albumin and the rising role of balanced salt solutions in clinical practice.
authors.affiliation: Hospital Pharmacy Services, Mayo Clinic , Rochester, Minnesota.
authors.forename: Erin N
authors.initials: EN
authors.lastname: Frazee
authors.affiliation: Hospital Pharmacy Services, Sanford Health , Fargo, North Dakota.
authors.forename: David D
authors.initials: DD
authors.lastname: Leedahl
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic , Rochester, Minnesota ; Division of Pulmonary and Critical Care Medicine, Mayo Clinic , Rochester, Minnesota.
authors.forename: Kianoush B
authors.initials: KB
authors.lastname: Kashani